The mediation effect of adiponectin on abdominal obesity–T2DM association was 41.02% after adjusting the confounders, including age, gender, SBP, DBP, coronary atherosclerotic heart disease, stroke, and family history of diabetes. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.